PH25186A - Fused azepinone and azocinone derivatives, agents containing them and their use - Google Patents

Fused azepinone and azocinone derivatives, agents containing them and their use

Info

Publication number
PH25186A
PH25186A PH36490A PH36490A PH25186A PH 25186 A PH25186 A PH 25186A PH 36490 A PH36490 A PH 36490A PH 36490 A PH36490 A PH 36490A PH 25186 A PH25186 A PH 25186A
Authority
PH
Philippines
Prior art keywords
azocinone
derivatives
agents containing
fused azepinone
azepinone
Prior art date
Application number
PH36490A
Other languages
English (en)
Inventor
Hansjoerg Urback
Rainer Henning
Bernhard Scholkens
Reinhard Becker
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PH25186A publication Critical patent/PH25186A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH36490A 1987-02-14 1988-02-12 Fused azepinone and azocinone derivatives, agents containing them and their use PH25186A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873704661 DE3704661A1 (de) 1987-02-14 1987-02-14 Annelierte azepinon- und azocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung

Publications (1)

Publication Number Publication Date
PH25186A true PH25186A (en) 1991-03-27

Family

ID=6320980

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36490A PH25186A (en) 1987-02-14 1988-02-12 Fused azepinone and azocinone derivatives, agents containing them and their use

Country Status (26)

Country Link
US (1) US4857520A (fi)
EP (1) EP0279350B1 (fi)
JP (1) JP2638034B2 (fi)
KR (1) KR960011376B1 (fi)
AR (1) AR246957A1 (fi)
AT (1) ATE97913T1 (fi)
AU (1) AU610124B2 (fi)
CA (1) CA1313371C (fi)
CZ (1) CZ280148B6 (fi)
DD (1) DD279877A5 (fi)
DE (2) DE3704661A1 (fi)
DK (1) DK172553B1 (fi)
ES (1) ES2061531T3 (fi)
FI (1) FI86849C (fi)
HU (2) HU203727B (fi)
IE (1) IE62354B1 (fi)
IL (1) IL85406A (fi)
JO (1) JO1524B1 (fi)
MA (1) MA21181A1 (fi)
MX (1) MX174166B (fi)
NO (1) NO176763C (fi)
NZ (1) NZ223500A (fi)
PH (1) PH25186A (fi)
PT (1) PT86748B (fi)
TN (1) TNSN88010A1 (fi)
ZA (1) ZA88991B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
PL353199A1 (en) * 1999-08-30 2003-11-03 Aventis Pharma Deutschland Gmbh Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354146A (en) * 1967-11-21 Process for the production of cyclo- pentano omega-oenantholactam
US4141893A (en) * 1976-11-02 1979-02-27 Eli Lilly And Company Decahydrocyclopent[c]azepines
CY1403A (en) * 1981-08-11 1987-12-18 Ciba Geigy Ag Benzazepin-2-ones
DE3373469D1 (en) * 1982-09-30 1987-10-15 Merck & Co Inc 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents
US4470988A (en) * 1983-02-10 1984-09-11 Ciba-Geigy Corporation Benzazocinone and benzazoninone derivatives, and their pharmaceutical use
DE3426720A1 (de) * 1984-07-20 1986-01-23 Hoechst Ag, 6230 Frankfurt Benzthiazepinon- und benzthiazocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung

Also Published As

Publication number Publication date
DK72488D0 (da) 1988-02-12
TNSN88010A1 (fr) 1990-07-10
NO880628L (no) 1988-08-15
DK172553B1 (da) 1999-01-11
FI880632A0 (fi) 1988-02-11
IL85406A0 (en) 1988-07-31
CZ280148B6 (cs) 1995-11-15
IL85406A (en) 1992-06-21
JP2638034B2 (ja) 1997-08-06
EP0279350A2 (de) 1988-08-24
DK72488A (da) 1988-08-15
IE880390L (en) 1988-08-14
AU1167288A (en) 1988-08-18
HU208425B (en) 1993-10-28
KR880009939A (ko) 1988-10-06
ZA88991B (en) 1988-08-10
DD279877A5 (de) 1990-06-20
NO176763C (no) 1995-05-24
FI880632A (fi) 1988-08-15
JPS63203665A (ja) 1988-08-23
DE3704661A1 (de) 1988-08-25
ES2061531T3 (es) 1994-12-16
AR246957A1 (es) 1994-10-31
MA21181A1 (fr) 1988-10-01
HUT48602A (en) 1989-06-28
NO176763B (no) 1995-02-13
FI86849B (fi) 1992-07-15
JO1524B1 (en) 1989-01-25
IE62354B1 (en) 1995-01-25
DE3885914D1 (de) 1994-01-13
EP0279350B1 (de) 1993-12-01
HU203727B (en) 1991-09-30
HUT50785A (en) 1990-03-28
CA1313371C (en) 1993-02-02
NZ223500A (en) 1990-11-27
KR960011376B1 (ko) 1996-08-22
PT86748A (pt) 1988-03-01
AU610124B2 (en) 1991-05-16
MX174166B (es) 1994-04-26
US4857520A (en) 1989-08-15
CZ89288A3 (en) 1994-12-15
FI86849C (fi) 1992-10-26
ATE97913T1 (de) 1993-12-15
EP0279350A3 (en) 1990-09-05
NO880628D0 (no) 1988-02-12
MX10408A (es) 1993-07-01
PT86748B (pt) 1992-04-30

Similar Documents

Publication Publication Date Title
EP0316718A3 (en) Azacyclic compounds and their preparation and use
GB8720863D0 (en) Metalloporphyrins
KR970002633B1 (en) Benzazepine and benzothiazephine derivatives
PH25713A (en) New 2-acylpyrrolidine derivatives, agents containing them, their use
EP0313969A3 (en) Tripeptide derivatives and antiplasmin agents containing the same
ZA882526B (en) Benzazepine derivatives
GB2206884B (en) 3-substituted benzazepines
GB2207427B (en) Benzazepine derivatives
JPS6468346A (en) Substituted anilinophenylthiourea, anilinophenylisothiourea and anilinophenylcarbodiimide
IL91335A0 (en) Dna sequence and hepadnavirus
PH25186A (en) Fused azepinone and azocinone derivatives, agents containing them and their use
GB2204870B (en) Benzazepine derivatives
IL86796A0 (en) Peptide derivatives,their preparation and their use
IL86022A0 (en) Pyrrolidine derivatives,their preparation,agents containing these derivatives,and their use
GB2204791B (en) Nootropic agent
GB8811385D0 (en) Nootropic agent
GB8700431D0 (en) Contrast agents
IE851222L (en) Benzazepine and benzodiazepine derivatives.
GB8722487D0 (en) Benzodiazepine derivatives
GB8729005D0 (en) Benzodiazepine derivatives
GB8718299D0 (en) Benzodiazepine derivatives
NZ221078A (en) Fused benzazepine derivatives and pharmaceutical compositions
ZA886538B (en) Lactam derivatives
ZA888366B (en) Azacyclic compounds,their preparation and use
GB8721284D0 (en) Antifolate agents